Home LiteratureArticle Details
PMID: 3760562 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Growth inhibition and cytotoxicity of tumor necrosis factor in L929 cells is enhanced by high cell density and inhibition of mRNA synthesis.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 137 ·No. 7 ·1986-10-01 ·Pages 2277-80

Kirstein M, Fiers W, Baglioni C

Abstract

L929 cells were growth-inhibited after 1 to 2 days of treatment with human recombinant tumor necrosis factor (rTNF). This effect of rTNF was largely reversible, and L929 cells resumed normal growth when rTNF was removed. The rTNF showed growth inhibitory and cytotoxic activity when L929 cells approached a high cell density and grew slowly. This was shown in experiments in which L929 cells approached confluency at different times after being seeded at increasing initial densities. The rTNF had little effect on the growth of cells seeded at the lowest density tested. L929 cells cultured to high density synthesized RNA at a reduced rate. This suggested that a reduced rate of RNA synthesis may be at least in part responsible for the growth inhibitory and cytotoxic activities of rTNF on cells grown to high density. Treatment with inhibitors of RNA synthesis potentiated the cytotoxic activity of rTNF. Inhibition of mRNA synthesis was apparently responsible for the enhanced sensitivity to rTNF, as shown by experiments with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole, an inhibitor of the synthesis of poly(A)-containing RNA.

MeSH Terms
Animals Cell Cycle/drug effects Cell Survival/drug effects Cells, Cultured Contact Inhibition Dactinomycin/pharmacology Dichlororibofuranosylbenzimidazole/pharmacology Drug Synergism Glycoproteins/pharmacology Growth Inhibitors L Cells Mice RNA, Messenger/biosynthesis Tumor Necrosis Factor-alpha
Chemicals
Glycoproteins Growth Inhibitors RNA, Messenger Tumor Necrosis Factor-alpha Dactinomycin Dichlororibofuranosylbenzimidazole
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Kirstein M
Fiers W
Baglioni C
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1986-10-01
Pages
2277-80
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NCI NIH HHS · CA29895 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com